The Nutshell

» cell & molecular biology and clinical trials

Daily News Roundup

Most Recent

If approved, patisiran will be the first RNAi therapeutic on the market. 

0 Comments

Research in human patients and mice reveals the role of the circadian clock in the risk of heart damage at different times of day.

1 Comment

image: FDA Goes After Two Stem Cell Clinics

FDA Goes After Two Stem Cell Clinics

By | August 29, 2017

The agency raided one that was using a stem cell-smallpox vaccine combo, and sent a warning to another to obey best practices.

0 Comments

image: Right-to-Try Bill Passes the Senate

Right-to-Try Bill Passes the Senate

By | August 4, 2017

The legislation removes restrictions for seriously ill patients to access experimental treatments that have not received FDA approval.

0 Comments

image: Cell Cannibalism as Cancer Defense

Cell Cannibalism as Cancer Defense

By | July 11, 2017

A new study suggests that the mysterious process by which one cell consumes another may be triggered by cell division, potentially helping to fight tumor growth.

0 Comments

In two early trials, vaccines tailored to the mutations in individuals’ cancers appeared to protect 12 of 19 patients against relapse. 

1 Comment

The cell-surface receptor, SIRP-alpha, initiates the innate immune response in hosts.  

0 Comments

image: Sex Reversal Mystery Explained?

Sex Reversal Mystery Explained?

By | June 15, 2017

A proposed mechanism for how bearded dragons with male chromosomes hatch as females at high temperatures

0 Comments

A new screening tool flags dozens of papers with potential errors.

0 Comments

The publicly available database found nearly a third of samples included mutations targeted by either approved drugs or therapies in clinical trials. 

0 Comments

Popular Now

  1. Secret Eugenics Conference Uncovered at University College London
  2. How Do Infant Immune Systems Learn to Tolerate Gut Bacteria?
  3. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  4. DOE-Sponsored Oak Ridge National Laboratory to Cut 100 More Jobs
AAAS